AR009293A1 - QUATERNARY AMMONIUM COMPOSITE C3-C7 CYCLLOALKYL SUBSTITUTED, COMPOSITIONS CONTAINING THEM, USE OF THE SAME FOR THE MANUFACTURE OF MEDICINAL PRODUCTS, PROCEDURE FOR THE PREPARATION - Google Patents

QUATERNARY AMMONIUM COMPOSITE C3-C7 CYCLLOALKYL SUBSTITUTED, COMPOSITIONS CONTAINING THEM, USE OF THE SAME FOR THE MANUFACTURE OF MEDICINAL PRODUCTS, PROCEDURE FOR THE PREPARATION

Info

Publication number
AR009293A1
AR009293A1 ARP970103804A ARP970103804A AR009293A1 AR 009293 A1 AR009293 A1 AR 009293A1 AR P970103804 A ARP970103804 A AR P970103804A AR P970103804 A ARP970103804 A AR P970103804A AR 009293 A1 AR009293 A1 AR 009293A1
Authority
AR
Argentina
Prior art keywords
alkyl
cycloalkyl
independently selected
substituted
alkylene
Prior art date
Application number
ARP970103804A
Other languages
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR009293A1 publication Critical patent/AR009293A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Un compuesto de amonio cuaternario C3-C7 cicloalquil sustituido, segun formula (I), en la que R es fenilo, cicloalquilo C3-C7 o heteroarilo, estandocada uno de ellos opcionalmente condensado con benceno o con cicloalquilo C3-C7 y opcionalmentes ustituidos, incluyendo la parte condensada con benceno o concicloalquilo C3-C7, con 1 a 3 sustituyentes seleccionados cada uno, independientemente, entre alquilo C1-C4, fluoroalquilo (C1-C4), alcoxi C1-C4,fluoroalcoxi(C1-C4), alcanoíloC2 -C4, halo, alcoxicarbonilo C1-C4, cicloalquilo C3-C7, -S(O)p(alquilo C1-C4), ciano, -NR7R8, -S(O)pNR7R8, -NR7(alcanoílo C1-C4) y -CONR7R8, o R es 2,3-dihidrobenzo[b]furanilo o cromanilo; R1 y R2 se seleccionan cada uno,independienteme nte, entre H y alquilo C1-C6 o,cuando se toman conjuntamente, son alquileno C2-C6; R3 y R4 se seleccionan cada uno, independientemente, entre H y alquilo C1-C6, cuando se tomanconjuntamente, son alquileno C1-C4 no ramificado; R5es fenilo, nafti lo, bencilo, tienilo, benzo[b]tienilo o indolilo, estando cada uno opcionalmentesustituido con 1 a 3 sustituyentes seleccionados cada uno, independientemente entre alquilo C1-C4, fluoroalquilo(C1-C4), alcoxi C1-C4, halo yciano, o R5 es1,3-b enzodioxolan-4 o 5-ilo o 1,4-benzodioxan-5 o 6-ilo; R6 es cicloalquilo C3-C7 opcionalmente sustituido con 1 a 3 sustituyentes seleccionados cada uno,independientemente, entre alquilo C1-C4, alcoxi C1-C4, halo, ciano, fluoroalquilo (C1 -C4) y fluoroalcoxi(C1-C4); R7 y R8 se seleccionan cada uno,independientemente, entre H y alquilo C1-C4 o, cuando se toman conjuntamente, son alquileno C4-C6; T es carbonilo; Y es alquileno C2-C4 no ramificado; Za esun anionfarmacéuticamente acept able; m es 0 o 1; n es 1 o 2; p es 0, 1 o 2; y heteroarilo, usado en la definicion de R, significa tienilo o un grupoA substituted C3-C7 cycloalkyl quaternary ammonium compound, according to formula (I), in which R is phenyl, C3-C7 cycloalkyl or heteroaryl, each being optionally fused with benzene or with C3-C7 cycloalkyl and optionally substituted, including the condensed part with benzene or C3-C7 cycloalkyl, with 1 to 3 substituents each independently selected from C1-C4 alkyl, fluoro (C1-C4) alkyl, C1-C4 alkoxy, fluoro (C1-C4) alkoxy, C2-C4 alkanoyl , halo, C1-C4 alkoxycarbonyl, C3-C7 cycloalkyl, -S (O) p (C1-C4 alkyl), cyano, -NR7R8, -S (O) pNR7R8, -NR7 (C1-C4 alkanoyl) and -CONR7R8, or R is 2,3-dihydrobenzo [b] furanyl or chromanyl; R1 and R2 are each independently selected from H and C1-C6 alkyl or, when taken together, are C2-C6 alkylene; R3 and R4 are each independently selected from H and C1-C6 alkyl, when taken together, are unbranched C1-C4 alkylene; R5 is phenyl, naphthyl, benzyl, thienyl, benzo [b] thienyl, or indolyl, each optionally being substituted with 1 to 3 substituents each independently selected from C1-C4 alkyl, (C1-C4) fluoroalkyl, C1-C4 alkoxy, halo ycian, or R5 is 1,3-b-enzyme-dioxolan-4 or 5-yl or 1,4-benzodioxan-5 or 6-yl; R6 is C3-C7 cycloalkyl optionally substituted with 1 to 3 substituents each independently selected from C1-C4 alkyl, C1-C4 alkoxy, halo, cyano, fluoroalkyl (C1-C4) and fluoroalkoxy (C1-C4); R7 and R8 are each independently selected from H and C1-C4 alkyl or, when taken together, are C4-C6 alkylene; T is carbonyl; Y is unbranched C2-C4 alkylene; Za is an anionpharmaceutically acceptable; m is 0 or 1; n is 1 or 2; p is 0, 1 or 2; and heteroaryl, used in the definition of R, means thienyl or a group

ARP970103804A 1996-08-23 1997-08-21 QUATERNARY AMMONIUM COMPOSITE C3-C7 CYCLLOALKYL SUBSTITUTED, COMPOSITIONS CONTAINING THEM, USE OF THE SAME FOR THE MANUFACTURE OF MEDICINAL PRODUCTS, PROCEDURE FOR THE PREPARATION AR009293A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9617730.8A GB9617730D0 (en) 1996-08-23 1996-08-23 Quarternary ammonium compounds

Publications (1)

Publication Number Publication Date
AR009293A1 true AR009293A1 (en) 2000-04-12

Family

ID=10798878

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103804A AR009293A1 (en) 1996-08-23 1997-08-21 QUATERNARY AMMONIUM COMPOSITE C3-C7 CYCLLOALKYL SUBSTITUTED, COMPOSITIONS CONTAINING THEM, USE OF THE SAME FOR THE MANUFACTURE OF MEDICINAL PRODUCTS, PROCEDURE FOR THE PREPARATION

Country Status (11)

Country Link
AP (1) AP9701074A0 (en)
AR (1) AR009293A1 (en)
AU (1) AU4015397A (en)
CO (1) CO4560548A1 (en)
GB (1) GB9617730D0 (en)
HR (1) HRP970451A2 (en)
ID (1) ID18069A (en)
MA (1) MA26436A1 (en)
PA (1) PA8436301A1 (en)
TN (1) TNSN97140A1 (en)
WO (1) WO1998007722A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1097137A1 (en) * 1998-07-10 2001-05-09 AstraZeneca AB N-substituted naphthalene carboxamides as neurokinin-receptor antagonists
GB9826941D0 (en) 1998-12-09 1999-02-03 Zeneca Pharmaceuticals Compounds
DE19938736A1 (en) 1999-08-16 2001-02-22 Bayer Ag Process for the preparation of [bis (trifluoromethyl) phenyl] acetic acids and their alkyl esters and [bis (trifluoromethyl) phenyl] malonic acid dialkyl ester
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
WO2008090117A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
CN110087729B (en) * 2016-12-14 2022-04-05 北京硕佰医药科技有限责任公司 Bifunctional compound with quaternary ammonium salt structure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696178B1 (en) * 1992-09-30 1994-12-30 Sanofi Elf Quaternary basic amides, process for their preparation and pharmaceutical compositions containing them.
EP0714891A1 (en) * 1994-11-22 1996-06-05 Eli Lilly And Company Heterocyclic tachykinin receptor antagonists

Also Published As

Publication number Publication date
WO1998007722A1 (en) 1998-02-26
AP9701074A0 (en) 1997-10-31
TNSN97140A1 (en) 2005-03-15
HRP970451A2 (en) 1998-08-31
ID18069A (en) 1998-02-26
PA8436301A1 (en) 2000-05-24
AU4015397A (en) 1998-03-06
CO4560548A1 (en) 1998-02-10
GB9617730D0 (en) 1996-10-02
MA26436A1 (en) 2004-12-20

Similar Documents

Publication Publication Date Title
AR007253A1 (en) PIRIMIDINE DERIVATIVES OR THEIR SALTS AND PHARMACEUTICALLY ACCEPTABLE N-OXIDES CONTAINING THE PHARMACEUTICAL COMPOSITION, PROCEDURE FOR PREPARING SUCH DERIVATIVES AND METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING ONE OF SUCH DERIVATIVES
ES2087665T3 (en) N-ACETONYL BENZAMIDES AND THEIR USE AS FUNGICIDES.
ES2060026T3 (en) 1H-IMIDAZO (4,5-C) QUINOLIN-4-OLEFINIC AMINES.
AR058967A2 (en) TRIAZOL DERIVATIVES [4,5-D] PIRIMIDINE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PREPARATION PROCESS FOR THOSE COMPOUNDS
ES2167371T3 (en) DERIVATIVES OF 1H-3-ARIL-PIRROLIDIN-2,4-DIONA SUBSTITUTED SPIROCYCLES.
AR035369A1 (en) DERIVATIVES OF TETRAHYDROBENZAZEPINA PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, THE USE OF SUCH DERIVATIVES IN THE MANUFACTURE OF MEDICINES, AND USEFUL INTERMEDIARIES IN THE PREPARATION OF SUCH COMPOUNDS
ES2038678T3 (en) PROCEDURE FOR THE PREPARATION OF N- (2-ALQUIL-3-MERCAPTO-GLUTARIL) -ALFAMINO-ACIDOS.
AR008291A1 (en) TETRAHYDROISOQUINOLINE DERIVATIVES, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE PREPARATION OF A MEDICINAL PRODUCT.
AR027539A1 (en) NEW DERIVATIVES OF 1,3-DIHIDRO-2H-INDOL-2-ONA, A PROCEDURE FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
AR009293A1 (en) QUATERNARY AMMONIUM COMPOSITE C3-C7 CYCLLOALKYL SUBSTITUTED, COMPOSITIONS CONTAINING THEM, USE OF THE SAME FOR THE MANUFACTURE OF MEDICINAL PRODUCTS, PROCEDURE FOR THE PREPARATION
ECSP034531A (en) SUBSTITUTED DERIVATIVES OF C-CICLOHEXILMETILAMINA
PT83725B (en) METHOD FOR PREPARING NEW 3-OXADIOL-BETA-CARBOLINE AND 3-CARBOXYLATE-BETA-CARBOLINE DERIVATIVES AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
AR012157A1 (en) DERIVATIVES OF PIRIDINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR THE PREPARATION OF SUCH DERIVATIVES.
AR036074A1 (en) DERIVATIVES OF AMINOQUINOLINE, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THE USE OF THE SAME FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION, A PROCEDURE FOR THEIR PREPARATION AND THE INTERMEDIARIES USED IN SUCH PREPARATION PROCEDURE
ATE245157T1 (en) 3,9-DIAZABICYCLO-(3.3.1)-NONANYL DERIVATIVES, METHODS AND INTERMEDIATES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PE20021018A1 (en) DERIVATIVES OF ß - CARBOLINE
ES2071666T3 (en) DERIVATIVES OF PIRAZOLOISOQUINOLINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
AR001813A1 (en) Chromone derivatives procedure for preparing them and the pharmaceutical compositions containing them
AR032303A1 (en) ISOTIAZOLCARBOXYLIC ACID DERIVATIVES, PROCEDURE FOR PREPARATION, COMPOSITION FOR THE CONTROL OF PLANT DISEASES, PROCEDURE TO COMBAT INDESEABLE MICROORGANISMS, USE OF SUCH DERIVATIVES TO COMBAT INDESEABLE MICROORGANISMS, PROCEDURE FOR PREPARATION
PT93360A (en) A process for the preparation of N- (1,4-BENZO-DIAZEPIN-3-YL) AMIDES OF 1H-INDOL-2-CARBOXYLIC ACID CONDENSED IN POSITIONS 1,7 AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR012249A1 (en) QUATERNARY AMMONIUM COMPOUNDS, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND THEIR USE FOR THE PREPARATION OF MEDICINES
ES2106936T5 (en) CARBAZOLONA DERIVATIVES AND PROCEDURES FOR PREPARATION.
ES2055115T3 (en) DERIVATIVES OF FENYL-AMIDINE AND FENYL-GUANIDINE SUBSTITUTED IN ORTO POSITION AND ANTIDIABETIC AND HYPOGLYCEMIC AGENTS THAT CONTAIN THEM.
PT96557A (en) METHOD FOR PREPARING ERGOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
FB Suspension of granting procedure